Duncan Moore Biography and Net Worth

Director of ASP Isotopes

Duncan Moore, Ph.D. has served on our board of directors since October 2021. Duncan is a partner at East West Capital Partners since May 2008, which has a focus on making investments in the Healthcare Industry in Asia. Previously, from 1991 to 2008, Duncan was a top-ranked pharmaceutical analyst at Morgan Stanley leading the firm’s global healthcare equity research team. Duncan was educated in Edinburgh and went to the University of Leeds where he studied Biochemistry and Microbiology. He has a M.Phil. and Ph.D. from the University of Cambridge where he was also a post-doctoral research fellow.

What is Duncan Moore's net worth?: The estimated net worth of Duncan Moore is at least $6.63 million as of August 29th, 2025. Dr. Moore owns 994,553 shares of ASP Isotopes stock worth more than $6,633,669 as of December 5th. This net worth estimate does not reflect any other assets that Dr. Moore may own. Learn More about Duncan Moore's net worth.
How do I contact Duncan Moore?: The corporate mailing address for Dr. Moore and other ASP Isotopes executives is , , . ASP Isotopes can also be reached via phone at 561-709-3034 and via email at [email protected]. Learn More on Duncan Moore's contact information.
Has Duncan Moore been buying or selling shares of ASP Isotopes?: Duncan Moore has not been actively trading shares of ASP Isotopes during the last quarter. Most recently, Duncan Moore sold 75,000 shares of the business's stock in a transaction on Friday, August 29th. The shares were sold at an average price of $9.28, for a transaction totalling $696,000.00. Following the completion of the sale, the director now directly owns 994,553 shares of the company's stock, valued at $9,229,451.84. Learn More on Duncan Moore's trading history.
Who are ASP Isotopes' active insiders?: ASP Isotopes' insider roster includes Robert Ainscow (COO), Paul Mann (CEO), Duncan Moore (Director), John Ryan (Director), and Todd Wider (Director). Learn More on ASP Isotopes' active insiders.
Are insiders buying or selling shares of ASP Isotopes?: During the last year, insiders at the sold shares 16 times. They sold a total of 1,590,019 shares worth more than $10,794,408.11. The most recent insider tranaction occured on December, 1st when Chairman Paul Elliot Mann sold 162,153 shares worth more than $932,379.75. Insiders at ASP Isotopes own 21.4% of the company. Learn More about insider trades at ASP Isotopes.
Information on this page was last updated on 12/1/2025.

Duncan Moore Insider Trading History at ASP Isotopes

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/29/2025	Sell	75,000	$9.28	$696,000.00	994,553
6/29/2023	Buy	100,000	$0.50	$50,000.00	550,000
5/10/2023	Buy	10,000	$0.50	$5,000.00	430,000
4/6/2023	Buy	20,000	$1.00	$20,000.00	420,000

Duncan Moore Buying and Selling Activity at ASP Isotopes

ASP Isotopes Company Overview

ASP Isotopes Inc., a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.

Today's Range

Now: $6.67

$5.94

$6.82

50 Day Range

MA: $8.77

$5.58

$14.05

2 Week Range

Now: $6.67

$3.65

$14.49

Volume

11,119,043 shs

Average Volume

6,628,717 shs

Market Capitalization

$739.30 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

3.41